oxcarbazepine
oxcarbazepine is listed in the FDA National Drug Code directory with 16 NDC codes, marketed under brand names including oxcarbazepine, Oxcarbazepine, Trileptal. Available dosage forms: tablet, tablet, film coated, powder, suspension, for suspension.
Drug Details
- Generic Name
- oxcarbazepine
- Brand Names
- oxcarbazepine, Oxcarbazepine, Trileptal
- Application Number
- ANDA211747
- Sponsor
- Zydus Lifesciences Limited
- NDC Codes
- 16
- Dosage Forms
- TABLET, TABLET, FILM COATED, POWDER, SUSPENSION, FOR SUSPENSION
- Routes
- ORAL
- Active Ingredients
- OXCARBAZEPINE
Indications and Usage
1 INDICATIONS AND USAGE Oxcarbazepine tablets is indicated for use as monotherapy or adjunctive therapy in the treatment of partial-onset seizures in adults and as monotherapy in the treatment of partial-onset seizures in pediatric patients aged 4 years and above, and as adjunctive therapy in pediatric patients aged 2 years and above with partial-onset seizures. Oxcarbazepine tablets is indicated for: Adults: Monotherapy or adjunctive therapy in the treatment of partial-onset seizures Pediatrics: Monotherapy in the treatment of partial-onset seizures in children 4–16 years Adjunctive therapy in the treatment of partial-onset seizures in children 2–16 years ( 1 )